CTR9 and breast carcinoma: Specifically, using loss-of-function approach, we observed that depletion of Ctr9 led to apparent morphological change, decrease of proliferation, reduced colony formation, and impaired ERα-target gene expression in ERα-positive breast cancer cells [16].